Interleukin_NN
1beta_NN
mediates_VBZ
the_DT
modulatory_JJ
effects_NNS
of_IN
monocytes_NNS
on_IN
LNCaP_NN
human_JJ
prostate_NN
cancer_NN
cells_NNS
._.

Proliferative_JJ
and_CC
secretory_JJ
responses_NNS
in_IN
androgen-sensitive_JJ
prostate_NN
cancer_NN
LNCaP_NN
cells_NNS
are_VBP
regulated_VBN
by_IN
steroid_NN
and_CC
peptide_NN
hormones_NNS
and_CC
by_IN
differentiation-promoting_JJ
substances_NNS
._.

In_IN
the_DT
present_JJ
study_NN
,_,
we_PRP
evaluated_VBD
whether_IN
peripheral_JJ
blood_NN
monocytes_NNS
that_WDT
exhibit_VBP
anti-tumour_JJ
activity_NN
in_IN
hematopoietic_JJ
and_CC
solid_JJ
tumors_NNS
influence_VBP
growth_NN
and_CC
secretion_NN
in_IN
the_DT
LNCaP_NN
cell_NN
line_NN
._.

For_IN
this_DT
purpose_NN
,_,
LNCaP_NN
cells_NNS
were_VBD
incubated_VBN
with_IN
monocyte-conditioned_JJ
medium_NN
-LRB-_-LRB-
MCM_NN
-RRB-_-RRB-
,_,
and_CC
proliferation_NN
as_RB
well_RB
as_IN
expression_NN
of_IN
androgen_NN
receptor_NN
-LRB-_-LRB-
AR_NN
-RRB-_-RRB-
and_CC
secretion_NN
of_IN
prostate-specific_JJ
antigen_NN
-LRB-_-LRB-
PSA_NN
-RRB-_-RRB-
were_VBD
assessed_VBN
._.

Conditioned_JJ
medium_NN
from_IN
monocytes_NNS
reduced_VBD
proliferation_NN
in_IN
a_DT
dose-dependent_JJ
manner_NN
._.

Incubation_NN
with_IN
40_CD
%_NN
MCM_NN
caused_VBD
a_DT
50_CD
%_NN
reduction_NN
in_IN
cell_NN
proliferation_NN
._.

AR_NN
protein_NN
decreased_VBN
by_IN
70_CD
%_NN
and_CC
PSA_NN
levels_NNS
in_IN
supernatants_NNS
from_IN
LNCaP_NN
cells_NNS
were_VBD
reduced_VBN
by_IN
approximately_RB
80_CD
%_NN
following_VBG
treatment_NN
with_IN
MCM_NN
._.

We_PRP
focused_VBD
on_IN
the_DT
contribution_NN
of_IN
two_CD
major_JJ
products_NNS
of_IN
activated_VBN
monocytes_NNS
,_,
prostaglandin_NN
E2_NN
and_CC
interleukin_NN
1beta_NN
-LRB-_-LRB-
IL-1beta_NN
-RRB-_-RRB-
,_,
to_TO
the_DT
MCM_NN
modulatory_JJ
action_NN
._.

LNCaP_NN
cells_NNS
treated_VBN
with_IN
prostaglandin_NN
E2_NN
showed_VBD
neither_CC
a_DT
reduction_NN
in_IN
proliferation_NN
nor_CC
a_DT
down-regulation_NN
of_IN
AR_NN
and_CC
PSA_NN
levels_NNS
._.

The_DT
effects_NNS
of_IN
MCM_NN
on_IN
cellular_JJ
proliferation_NN
,_,
AR_NN
protein_NN
and_CC
PSA_NN
secretion_NN
were_VBD
abolished_VBN
by_IN
pretreatment_NN
of_IN
MCM_NN
with_IN
a_DT
neutralizing_VBG
anti-IL-1beta_NN
antibody_NN
._.

In_IN
addition_NN
,_,
recombinant_JJ
IL-1beta_NN
was_VBD
able_JJ
to_TO
replace_VB
MCM_NN
for_IN
the_DT
inhibition_NN
of_IN
proliferation_NN
and_CC
down-regulation_NN
of_IN
AR_NN
and_CC
PSA_NN
proteins_NNS
._.

LNCaP_NN
cells_NNS
were_VBD
shown_VBN
to_TO
express_VB
the_DT
IL-1beta_NN
receptor_NN
type_NN
1_CD
,_,
which_WDT
transduces_VBZ
IL-1beta_NN
signal_NN
._.

Our_PRP$
findings_NNS
reveal_VBP
that_IN
monocyte-derived_JJ
IL-1beta_NN
inhibits_VBZ
the_DT
proliferation_NN
of_IN
androgen-responsive_JJ
prostate_NN
tumor_NN
cells_NNS
and_CC
reduces_VBZ
AR_NN
and_CC
PSA_NN
levels_NNS
._.

